Episode 1: The Sympathy Play

Host John Carreyrou and reporter Emily Saul revisit the drama of Elizabeth Holmes’s guilty verdict, dissect its meaning, and discuss sentencing. And a surprise guest comes on the show. Learn more about your ad choices. Visit podcastchoices.com/adchoices 

With a conference call, a magazine interview and a doctored pharmaceutical report, Elizabeth Holmes convinced a small group of very wealthy investors to put hundreds of millions of dollars in her unproven blood-testing startup. Learn more about your ad choices. Visit podcastchoic ...  Show more

When Elizabeth Holmes founded Theranos, the blood testing start-up, she was held up as one of the next great tech innovators.

But her company collapsed, and she was accused of lying about how well Theranos’s technology worked. Now she is on trial on fraud charges.

...

The upcoming criminal trial of former Theranos CEO Elizabeth Holmes figures to center around one crucial question: Was the blood testing startup’s failure a case of misguided Silicon Valley over-ambition, or was it outright fraud? Law360’s Dorothy Atkins has been covering the The ...  Show more

Elizabeth Holmes has been found guilty of fraud. We ask what lessons her downfall holds for Theranos’s high-profile backers—and for a startup culture of hype before science. As Apple crosses a $3trn valuation we examine the motives for its stop-start forays into the competitiv ...

Starting Aug. 31, in a series of new episodes, "The Dropout: Elizabeth Holmes on Trial" will take you inside the courtroom, breaking down the evidence and keeping score for both sides until 12 jurors decide the fate of the Theranos founder and new mother. Three years after she wa ...  Show more